Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

112.49
-1.6000-1.40%
Post-market: 112.870.3800+0.34%19:52 EDT
Volume:7.26M
Turnover:818.28M
Market Cap:139.58B
PE:22.45
High:114.05
Open:113.45
Low:112.15
Close:114.09
52wk High:121.83
52wk Low:81.83
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.96
T/O Rate:0.59%
Dividend:3.12
Dividend Rate:2.77%
EPS(TTM):5.01
EPS(LYR):0.3849
ROE:33.40%
ROA:12.62%
PB:7.09
PE(LYR):292.24

Loading ...

Ideaya Reports 'Positive' Initial Data on Trodelvy Combination Trial in Urothelial Cancer

MT Newswires Live
·
Sep 08

Wyoming Treasurer Buys European Bank Stocks, Ups CVS Stake -- Barron's

Dow Jones
·
Sep 06

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 06

US plans to bring Gilead HIV drug to market in high-burden HIV countries

Reuters
·
Sep 05

Gilead Sciences Partners with U.S. State Department and PEPFAR to Accelerate Lenacapavir Approval and Access for HIV Prevention in High-Incidence Countries

Reuters
·
Sep 05

Gilead Announces Partnership With Pepfar to Deliver Twice-Yearly Lenacapavir for Hiv Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

THOMSON REUTERS
·
Sep 05

Gilead to Offer Lenacapavir to Global Fund, U.S. Govt’s Pepfar Program “at Cost” and Without Profit -U.S. State Dept

THOMSON REUTERS
·
Sep 05

U.S. Announces Plan to Bring U.S.-Based Gilead Sciences’ Drug Lenacapavir to Market in High-Burden Hiv Countries

THOMSON REUTERS
·
Sep 05

Gilead Sciences Breaks Ground on New Manufacturing Center at California HQ

MT Newswires Live
·
Sep 04

Gilead starts building manufacturing hub under $32 billion planned US investments

Reuters
·
Sep 04

Gilead Sciences Inc. Expands U.S. Operations with New Bay Area Manufacturing and Development Hub

Reuters
·
Sep 03

Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy

THOMSON REUTERS
·
Sep 03

Pharming Group NV Appoints Kenneth Lynard as New Chief Financial Officer Effective October 2025

Reuters
·
Sep 02

Wyoming State Buys European Bank Stocks, Adjusts Healthcare Holdings -- Barrons.com

Dow Jones
·
Sep 01

Daniel Patrick O'Day, Chairman & CEO, Reports Disposal of Gilead Sciences Inc. Common Shares

Reuters
·
Aug 30

Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Aug 29

Yuhan Secures HCV API Supply Contract from Gilead Sciences

MT Newswires Live
·
Aug 27

Gilead Sciences Advances Global PrEP Access with Regulatory Filings for Lenacapavir in Australia, Brazil, Canada, South Africa, and Switzerland

Reuters
·
Aug 26

BRIEF-Gilead Sciences Says European Commission Authorizes Twice-Yearly Yeytuo For HIV Prevention

Reuters
·
Aug 26

Gilead Sciences: Lenacapavir to Be Granted 1 Extra Year of Market Protection in EU

THOMSON REUTERS
·
Aug 26